ArticleObesity (Silver Spring, Md.)2025

Reasons for Discontinuation of Obesity Pharmacotherapy With Semaglutide or Tirzepatide in Clinical Practice.

Hamlet Gasoyan et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.